In summary, we find the transcriptional consequences of JAK2 exon 12 mutations in clonal erythroblasts from PV patients to be indistinguishable from those of het- erozygous JAK2V617F in ET. In contrast to JAK2V617F- positive PV, patients with exon 12 mutations show no evidence of attenuated STAT1 activation, demonstrating that this impairment is not necessary for an erythrocytosis. […]STAT1 activation has been associated with enhanced megakaryopoiesis and may contribute to the thrombocytosis observed in 20% of patients with exon 12 mutations, whilst absence of thrombocytosis in others may reflect STAT1-independent mechanisms such as accelerated platelet destruction. Taken together our data support the concept that the development of a PV or ET phe- notype reflects combinations of mechanisms that operate differently between individuals, and that, furthermore, these mechanisms differ between classes of JAK2 mutation.

MicroRNA-101 expression is associated with JAK2V617F activity and regulates JAK2/STAT5 signaling / Pagano, Francesca; Comoglio, Federico; Grinfeld, Jacob; Li, Juan; Godfrey, Anna; Baxter, Joanna; Silber, Yvonne; Green, Anthony R. - In: LEUKEMIA. - ISSN 0887-6924. - ELETTRONICO. - 32:8(2018), pp. 1826-1830. [10.1038/s41375-018-0053-9]

MicroRNA-101 expression is associated with JAK2V617F activity and regulates JAK2/STAT5 signaling

Pagano, Francesca
Writing – Original Draft Preparation
;
2018

Abstract

In summary, we find the transcriptional consequences of JAK2 exon 12 mutations in clonal erythroblasts from PV patients to be indistinguishable from those of het- erozygous JAK2V617F in ET. In contrast to JAK2V617F- positive PV, patients with exon 12 mutations show no evidence of attenuated STAT1 activation, demonstrating that this impairment is not necessary for an erythrocytosis. […]STAT1 activation has been associated with enhanced megakaryopoiesis and may contribute to the thrombocytosis observed in 20% of patients with exon 12 mutations, whilst absence of thrombocytosis in others may reflect STAT1-independent mechanisms such as accelerated platelet destruction. Taken together our data support the concept that the development of a PV or ET phe- notype reflects combinations of mechanisms that operate differently between individuals, and that, furthermore, these mechanisms differ between classes of JAK2 mutation.
2018
microRNA; hematopoiesis; molecular mechanism
01 Pubblicazione su rivista::01a Articolo in rivista
MicroRNA-101 expression is associated with JAK2V617F activity and regulates JAK2/STAT5 signaling / Pagano, Francesca; Comoglio, Federico; Grinfeld, Jacob; Li, Juan; Godfrey, Anna; Baxter, Joanna; Silber, Yvonne; Green, Anthony R. - In: LEUKEMIA. - ISSN 0887-6924. - ELETTRONICO. - 32:8(2018), pp. 1826-1830. [10.1038/s41375-018-0053-9]
File allegati a questo prodotto
File Dimensione Formato  
Pagano_MicroRNA-101_2018.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 794.25 kB
Formato Adobe PDF
794.25 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1079084
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
social impact